Literature DB >> 32160670

Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis.

Harold A Chapman1, Ying Wei1, Genevieve Montas1, Darren Leong1, Jeffrey A Golden1, Binh N Trinh1, Paul J Wolters1, Claude J Le Saux1, Kirk D Jones1, Nancy K Hills1, Elena Foster2, Justin M Oldham2, Angela L Linderholm2, Prerna Kotak3, Martin Decaris3, Scott Turner3, Jin-Woo Song4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32160670      PMCID： PMC7297220          DOI： 10.1056/NEJMc1915189

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.

Authors:  Ying Wei; Thomas J Kim; David H Peng; Dana Duan; Don L Gibbons; Mitsuo Yamauchi; Julia R Jackson; Claude J Le Saux; Cheresa Calhoun; Jay Peters; Rik Derynck; Bradley J Backes; Harold A Chapman
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

2.  Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.

Authors:  Toby M Maher; Susanne Stowasser; Yasuhiko Nishioka; Eric S White; Vincent Cottin; Imre Noth; Moisés Selman; Klaus B Rohr; Andreas Michael; Carina Ittrich; Claudia Diefenbach; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2019-07-17       Impact factor: 30.700

3.  Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).

Authors:  Mario E Lacouture; John C Morris; Donald P Lawrence; Antoinette R Tan; Thomas E Olencki; Geoffrey I Shapiro; Bruce J Dezube; Jay A Berzofsky; Frank J Hsu; Joan Guitart
Journal:  Cancer Immunol Immunother       Date:  2015-01-13       Impact factor: 6.968

4.  Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.

Authors:  Margaret Neighbors; Christopher R Cabanski; Thirumalai R Ramalingam; X Rebecca Sheng; Gaik W Tew; Chunyan Gu; Guiquan Jia; Kun Peng; Jill M Ray; Brett Ley; Paul J Wolters; Harold R Collard; Joseph R Arron
Journal:  Lancet Respir Med       Date:  2018-06-29       Impact factor: 30.700

Review 5.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694
  5 in total
  9 in total

1.  MUC4 is overexpressed in idiopathic pulmonary fibrosis and collaborates with transforming growth factor β inducing fibrotic responses.

Authors:  Javier Milara; Beatriz Ballester; M J Safont; Enrique Artigues; Juan Escrivá; Esteban Morcillo; Julio Cortijo
Journal:  Mucosal Immunol       Date:  2020-09-04       Impact factor: 7.313

Review 2.  Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.

Authors:  Zhichao Zhang; Xiangchun Zhang; Keyi Bi; Yufeng He; Wangjun Yan; Chung S Yang; Jinsong Zhang
Journal:  Trends Food Sci Technol       Date:  2021-05-25       Impact factor: 16.002

Review 3.  The COVID-19 pandemic: catching up with the cataclysm.

Authors:  Surajit Chakraborty; Anirban Basu
Journal:  F1000Res       Date:  2020-06-23

Review 4.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 5.  Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases.

Authors:  Lara Perryman; Steven G Gray
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 6.  Potential Application of Tea Polyphenols to the Prevention of COVID-19 Infection: Based on the Gut-Lung Axis.

Authors:  Lei Xu; Chi-Tang Ho; Yanan Liu; Zufang Wu; Xin Zhang
Journal:  Front Nutr       Date:  2022-04-14

7.  Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level.

Authors:  Danfeng Zhang; Yadan Li; Chunyan Du; Lina Sang; Liu Liu; Yingmei Li; Fang Wang; Wenjuan Fan; Ping Tang; Sidong Zhang; Dandan Chen; Yanmei Wang; Xiaoyi Wang; Xinsheng Xie; Zhongxing Jiang; Yongping Song; Rongqun Guo
Journal:  J Transl Med       Date:  2022-08-12       Impact factor: 8.440

8.  Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis.

Authors:  Ying Wei; Wenting Dong; Julia Jackson; Tsung-Che Ho; Claude Jourdan Le Saux; Alexis Brumwell; Xiaopeng Li; Julia Klesney-Tait; Max L Cohen; Paul J Wolters; Harold A Chapman
Journal:  Thorax       Date:  2021-01-20       Impact factor: 9.102

9.  Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis.

Authors:  Prathibha R Gajjala; Rajesh K Kasam; Divyalakshmi Soundararajan; Debora Sinner; Steven K Huang; Anil G Jegga; Satish K Madala
Journal:  JCI Insight       Date:  2021-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.